Applying two inhibitors—YM155 and UFSHR—to primary pancreatic cancer cell lines reduced their survivin expression and showed pro-apoptotic, anti-migratory, and anti-proliferative effects as expected. The gene discussed is BIRC5; the disease is pancreatic neoplasm.